Intervention
Contingency Management
ClinicalTrials.gov intervention label
Clinical trials
19 shownReducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.NCT07281378 · 2026-09-13
NOT_YET_RECRUITINGContingency Management for Problematic Behavior Reduction in the CommunityNCT06486584 · 2023-06-20
COMPLETEDASK-PrEP (Assistance Services Knowledge-PrEP)NCT05934877 · 2023-05-11
TERMINATEDExpression of Stress Markers During Meth Treatment (EXPRESS+)NCT05558345 · 2022-09-01
UNKNOWNTrauma Intervention to Optimize PrEP Among Women Who Inject DrugsNCT05192434 · 2022-06-17
ACTIVE_NOT_RECRUITINGInflammation in Methamphetamine and STIs (IMSTI)NCT05162391 · 2022-05-31
COMPLETEDDiabetes Smoking Cessation Incentives StudyNCT04682067 · 2021-01-08
COMPLETEDA Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIVNCT04490057 · 2020-07-27
COMPLETEDEffects of Cannabis Abstinence on Symptoms and Cognition in DepressionNCT03624933 · 2017-11-06
COMPLETEDTrauma Intervention for Affect Regulation, AIDS, and SubstancesNCT02923141 · 2017-01-01
COMPLETEDEffectiveness of Peer Navigation and Contingency Management on Retention in HIV CareNCT02310893 · 2016-01-01
COMPLETEDPre to Postoperative Smoking CessationNCT02683161 · 2015-10-01
TERMINATEDContingency Management of Alcohol Abuse in the Severely Mentally ILLNCT01567943 · 2012-03-01
COMPLETEDImproving Antihypertensive Medication AdherenceNCT01296594 · 2011-02-01
COMPLETEDReduction of Drug Use and HIV Risk Among Out-of-Treatment Methamphetamine UsersNCT01161485 · 2010-08-01
COMPLETEDInterventionist Procedures for Adherence to Weight Loss Recommendations in Black AdolescentsNCT01350531 · 2009-09-01
UNKNOWNContingency Management of Psychostimulant Abuse in the Severely Mentally IllNCT00809770 · 2008-04-01
COMPLETEDContingency Management for Smoking Cessation Among Veterans With Psychotic DisordersNCT00508560 · 2007-07-01
TERMINATEDTreatment of Heroin and Cocaine With Methadone Maintenance and Contingency ManagementNCT00292110 · 2004-02-01
COMPLETEDCommon conditions
Bipolar Disorder3Major Depressive Disorder3Schizophrenia3HIV2HIV Infections2Obesity2Alcohol Abuse1Anosognosia1Cannabis Use Disorder1Cigarette Smoking1Cocaine-Related Disorders1Cognition1Diabetes Type 21Drug Abuse1Drug Use Disorders1High Blood Pressure1HIV Risk Behavior1HIV/AIDS1Human Immunodeficiency Virus1Methamphetamine-dependence1Nicotine Dependence1Opiate-Related Disorders1Opioid Use1Post Traumatic Stress Disorder1PrEP Adherence1
Leading sponsors
University of California, Los Angeles3University of Washington2Centre for Addiction and Mental Health1Drexel University1Friends Research Institute, Inc.1Johns Hopkins University1Laureate Institute for Brain Research, Inc.1National Institute on Drug Abuse (NIDA)1UConn Health1University of Colorado, Denver1University of Florida1University of Miami1University of Oklahoma1US Department of Veterans Affairs1Wayne State University1
Trial status mix
COMPLETED12
TERMINATED3
UNKNOWN2
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
Phase mix
NA16
PHASE11
PHASE21
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.